Eli Lilly, InSilico Strike AI Drug Discovery Deal - WSJ
Eli Lilly, InSilico Strike AI Drug Discovery Deal WSJ
Could not retrieve the full article text.
Read on GNews AI drug discovery →Sign in to highlight and annotate this article
Conversation starters
Daily AI Digest
Get the top 5 AI stories delivered to your inbox every morning.
Knowledge Map
Connected Articles — Knowledge Graph
This article is connected to other articles through shared AI topics and tags.
More in Analyst News
Vibe analyzing my genome
The most interesting and useful result concerns drug metabolism; you can skip to that section here . I would like to reduce the up and down fluctuations of my Bipolar. They're simultaneously not that bad, but also bad enough to be unpleasant, disruptive, and to rob me of many productive hours. Bipolar, for all its prevalence and study [1] , is not yet well understood. It's maybe something something a circadian rhythm disorder. It's maybe something something inflammatory. It's maybe a single disease with somewhat different presentations, or maybe it's multiple diseases with somewhat similar presentation. I hoped that if I could look at my own genes and see which were anomalous, perhaps I could pin down what's going wrong in my mind. If it seems to be clock gene-related, I'll emphasize circa
Discussion
Sign in to join the discussion
No comments yet — be the first to share your thoughts!